Press Releases

NEW YORK--(BUSINESS WIRE)-- Xtrackers by DWS, one of the world's largest and most established providers of exchange traded funds, announced plans to close its Xtrackers S&P 600 SmallCap ESG ETF, a U.S.-listed exchange traded fund (ETF) (the “Fund”) effective May 24, 2024, and to liquidate the Fund effective June 5, 2024. The Fund currently trades on the NYSE Arca exchange (the “Exchange”).

After the close of business on May 24, 2024, the Fund will no... (continue reading...)

CALGARY, Alberta--(BUSINESS WIRE)-- Forward Summit is proud to announce that National Chief Cindy Woodhouse Nepinak will inaugurate this year’s conference, scheduled to take place on May 14 and 15 at the Grey Eagle in Tsuut'ina Nation, Calgary. This distinguished event gathers an influential roster of Grand Chiefs, Chiefs, Métis Leaders, community liaisons, and senior industry representatives, all coming together for discussions to advance economic partnerships... (continue reading...)

LOUISVILLE, Ky., May 08, 2024 (GLOBE NEWSWIRE) -- LogicMark, Inc. (Nasdaq: LGMK), a provider of personal emergency response systems (PERS), health communications devices, and technology for the growing care economy, today announced that Ms. Chia-Lin Simmons, CEO, and Mr. Mark Archer, CFO will speak at the virtual Aegis Capital Corp. Conference on Thursday, May 9th at 11:00 PDT / 2:00 pm EDT.

Please register here to attend the conference: ... (continue reading...)

• First quarter results supported by strong grower demand for crop inputs, increased potash shipments to key global markets, higher fertilizer operating rates and lower costs.
• Maintaining full-year 2024 Retail adjusted EBITDA and fertilizer sales volume guidance ranges.

All amounts are in US dollars except as otherwise noted

SASKATOON, Saskatchewan--(BUSINESS WIRE)-- Nutrien Ltd. (TSX and NYSE: NTR) announced today its first quarter 2024 results, with net... (continue reading...)

CHARLOTTESVILLE, Va., May 08, 2024 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers for the treatment of Alzheimer’s disease, announced today that management will participate in a fireside chat at the 2024 Bank of America Healthcare Conference on Wednesday, May 15, 2024, at 8:55 a.m. PT (11:55 a.m. ET).

The live webcast may be... (continue reading...)